Filter results by: Taxon Proteome
1 - 50 of 5394 UniProtKB matches
(6915 models, 1539 structures.)
UniProtKB AC
(Name)
UniProtKB Section
 
Homology Model
 
Experimental Structure
OrganismDescription
Q8I295
(ISPH_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
4-hydroxy-3-methylbut-2-enyl diphosphate reductase, apicoplast;
Q8IBP3
(ITPA_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Inosine triphosphate pyrophosphatase;
Non-canonical purine NTP pyrophosphatase;
Non-standard purine NTP pyrophosphatase;
Nucleoside-triphosphate diphosphatase;
Nucleoside-triphosphate pyrophosphatase;
XTP/dITP diphosphatase;
Q8IJV6
(KAD1_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Adenylate kinase 1;
Q8IB06
(KAD2_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Adenylate kinase 2;
Q8I1T1
(KAD3_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
GTP:AMP phosphotransferase;
Q8I236
(KAD6_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Adenylate kinase isoenzyme 6 homolog;
Dual activity adenylate kinase/ATPase;
PfAKLP1;
C0H582
(KADL_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Inactive adenylate kinase;
Adenylate kinase-like protein 2;
Q8IHZ9
(KC1_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Casein kinase I;
Casein kinase 1;
Q8I5E6
(KCH1_PLAF7)
Swiss-ProtPlasmodium falciparum
(isolate 3D7)
Potassium channel K1;
Q8IKI3
(KCH2_PLAF7)
Swiss-ProtPlasmodium falciparum
(isolate 3D7)
Potassium channel K2;
Q8I719
(KGP_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
cGMP-dependent protein kinase;
PfPKG;
Q8I4S1
(KTHY_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Thymidylate kinase;
Thymidine monophosphate kinase;
Thymidylate/guanylate kinase;
Q8IDQ0
(LIPA_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Lipoyl synthase, apicoplast;
Lipoate synthase;
Lipoic acid synthase;
Q8IEG9
(LIPLA_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Lipoate--protein ligase 1;
Q8I2S0
(LIPLB_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Inactive lipoate--protein ligase 2;
C6KSS5
(LRR2_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Protein PFF0380w;
O77384
(LRR4_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Protein PFC0760c;
Q6LFH8
(OAT_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Ornithine aminotransferase;
Ornithine--oxo-acid aminotransferase;
Q8I615
(ORC1_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Origin recognition complex subunit 1;
O96237
(ORC5_PLAF7)
Swiss-ProtPlasmodium falciparum
(isolate 3D7)
Origin recognition complex subunit 5;
Q8ILP3
(P113_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Surface protein P113;
O96175
(P230P_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Male gametocyte surface protein P230p;
P68874
(P230_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Gametocyte surface protein P230;
Q8I6T1
(P4548_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Gametocyte surface protein P45/48;
P61074
(PCNA1_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
DNA sliding clamp PCNA1;
Proliferating cell nuclear antigen 1;
Q7KQJ9
(PCNA2_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
DNA sliding clamp PCNA2;
Proliferating cell nuclear antigen 2;
Q8I5V4
(PDEA_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
cGMP-specific 3',5'-cyclic phosphodiesterase alpha;
Q8I6Z7
(PDEB_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase beta;
Q8IKD3
(PDED_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
cGMP-specific 3',5'-cyclic phosphodiesterase delta;
C6KT50
(PDX1_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Pyridoxal 5'-phosphate synthase subunit Pdx1;
Q8IIK4
(PDX2_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Pyridoxal 5'-phosphate synthase subunit PDX2;
Pyridoxal 5'-phosphate synthase glutaminase subunit;
Q8IIS5
(PESC_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Pescadillo homolog;
O77374
(PF07_PLAF7)
Swiss-ProtPlasmodium falciparum
(isolate 3D7)
Uncharacterized protein PFC0810c;
C0H4K2
(PF08_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Uncharacterized protein;
C6KSX1
(PF12P_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Surface protein P12p;
C6KSX0
(PF12_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Merozoite surface protein P12;
Merozoite surface protein P12, processed form;
Q8I1Y4
(PF36P_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Sporozoite surface protein P36p;
Sporozoite surface protein P52;
Q8I1Y5
(PF36_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Sporozoite surface protein P36;
Q8I423
(PF38_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Merozoite surface protein P38;
Q8I1Y0
(PF41_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Merozoite surface protein P41;
Merozoite surface protein P41, processed form;
Q8ID66
(PF92_PLAF7)
Swiss-ProtPlasmodium falciparum
(isolate 3D7)
Merozoite surface protein P92;
C6KT40
(PFC43_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Ookinete surface protein PIMMS43;
Q8I3Y6
(PFD6_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Probable prefoldin subunit 6;
Q8IIR7
(PFERC_PLAF7)
Swiss-ProtPlasmodium falciparum
(isolate 3D7)
Endoplasmic reticulum-resident calcium binding protein;
Pf39;
Pfs40;
Q6ZMA7
(PFS16_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Parasitophorous vacuole membrane protein S16;
Sexual stage-specific protein S16;
Q8IDN0
(PFS47_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Female gametocyte surface protein P47;
6-cysteine protein P47;
P27362
(PGK_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Phosphoglycerate kinase;
3-phosphoglycerate kinase;
Q8IBV0
(PGP_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Phosphoglycolate phosphatase;
Q8IJP2
(MAP1B_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Methionine aminopeptidase 1b;
PfMetAP1b;
Q8IDF3
(MCA1_PLAF7)
Swiss-Prot
Plasmodium falciparum
(isolate 3D7)
Metacaspase-1;
PfMCA1;
Large subunit p20;
Small subunit p10;
1 - 50 of 5394
Plasmodium falciparum (isolate 3D7)

Plasmodium falciparum is a protozoan parasite that resides in human red blood cells, but can also infect the brain and liver. P. falciparum is one of the species of Plasmodium that causes malaria in humans. It has a complex life-cycle requiring both human and female Anopheles mosquito. P. falciparum is responsible for the disease's most dangerous form, malignant or falciparum malaria, which has the highest complication rates and mortality.

With more than 200 million cases and 400,000 deaths from malaria worldwide, P. falciparum (causing roughly 50% of the cases) has been the focus of malaria research for decades.

The genome of P. falciparum was first sequenced in 2002.

"Plasmodium falciparum", Wikipedia: The Free Encyclopedia

Protein models in Repository

From left to right: i) The number of proteins in the reference proteome of Plasmodium falciparum, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Plasmodium falciparum for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.

For information on the latest proteome for Plasmodium falciparum, please visit UniProtKB.

You can easily download the latest protein sequences for Plasmodium falciparum proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_02 that was used for the most up to date SWISS-MODEL Repository.

Proteins in proteomeSequences modelledModels
5,3613,9006,883

Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.

Structural Coverage

The plot shows the evolution over years (x-axis) of the fraction of Plasmodium falciparum reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.

Residue Coverage

This chart shows the percentage of residues in the Plasmodium falciparum proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.

Oligomeric State

Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.

Single Chain2-mer3-mer4-mer5-mer6-mer7-mer8-mer9-mer10-mer12-mer14-mer16-mer19-mer20-mer21-mer24-mer32-mer40-mer60-mer
6,199474376894995149331113133
Download